Immunology and Microbiology
B Cell
100%
Sjögren's Syndrome
74%
Salivary Gland
57%
T Cell
28%
Rheumatoid Factor
17%
Follicular B Helper T Cells
16%
Parotid Gland
13%
Plasma Cell
13%
T-Helper Cell
12%
Rituximab
12%
Interleukin 17
12%
Gland Tissue
11%
Autoantibodies
11%
Vaccination Policy
10%
Epitope
10%
Cytokine
10%
Th17 Cell
10%
Abatacept
9%
Autoimmune Disease
9%
Autoimmunity
8%
Germinal Center
8%
Memory B Cell
8%
Lymphocyte
7%
Bruton Tyrosine Kinase
7%
Immunocompetent Cell
6%
interferon
6%
B-Cell Receptor
6%
Sialadenitis
6%
Inflammatory Arthritis
6%
Homeostasis
6%
Stem Cell
6%
Antibody Secreting Cell
6%
Light Chain
6%
Immunoglobulin Blood Level
6%
Vaccine Efficacy
6%
CD38
5%
Co-Stimulation
5%
B Cell Activating Factor Receptor
5%
Autoimmune Rheumatic Disease
5%
Giant Cell Arteritis
5%
Plasmacytoid Dendritic Cell
5%
Coronavirinae
5%
Macrophage
5%
Pathogenicity
5%
Gene Expression Profiling
5%
Transcriptome
5%
Antibody Response
5%
COVID-19
5%
Cell Aging
5%
Immunogenicity
5%
Medicine and Dentistry
Sjoegren Syndrome
47%
Salivary Gland
45%
B Cell
41%
Disease
34%
Biopsy
32%
T Cell
19%
Parotid Gland
18%
Abatacept
14%
Gland Tissue
14%
Disease Activity
14%
Vaginal Dryness
14%
Biological Marker
13%
Hyperactivity
12%
Symptom
12%
B Lymphocyte
10%
Transcriptome
10%
Pediatrics
10%
Interferon
10%
T-Helper Cell
10%
Lymphocyte
9%
T Follicular Helper Cell
9%
MALT Lymphoma
8%
Salivary Gland Biopsy
7%
Tfh Cell
7%
Immunocompetent Cell
7%
Interleukin 17
6%
Drug Therapy
6%
Memory B Cell
6%
Antibody Secreting Cell
6%
Disease Severity
6%
Histopathology
6%
Rheumatoid Factor
5%
Receptor Binding
5%
Systemic Lupus Erythematosus
5%
Diagnostic Accuracy
5%
Early Intervention
5%
COVID-19 Vaccination
5%
Physical Performance
5%
Immunogenicity
5%
Antibody Response
5%
Stem Cell
5%
Adverse Event
5%
Case-Control Study
5%
Fatigue Impact Scale
5%
Co-Stimulation
5%
Retrospective Cohort Study
5%
Mucosa-Associated Lymphoid Tissue
5%
Fatigue Severity Scale
5%
Coronavirinae
5%
Severe Acute Respiratory Syndrome Coronavirus 2
5%
Keyphrases
Primary Sjgren's Syndrome
40%
B Cells
25%
Primary Sjögren's Syndrome
24%
Sjgren's Syndrome
15%
Clinical Trials
11%
T Cells
8%
Rituximab
8%
B Cell Depletion Therapy
8%
Phase II Trial
7%
Salivary Gland
6%
Tfh Cells
6%
Daily Clinical Practice
6%
B Lymphocytes
6%
Circulating B Cells
6%
Working Diagnosis
5%
Lymphoepithelial Lesion
5%
European League against Rheumatism (EULAR)
5%
Interferon Signaling
5%
Inducible Costimulator
5%
Perfect Storm
5%
Vaginal Tissue
5%
Lymphoma
5%
Early Intervention
5%
Rheumatology
5%
Pharmacology
5%
Autoimmune Disease
5%
T Follicular Regulatory
5%
Physical Performance
5%
Macrophages
5%
Extraglandular
5%
Pharmacological Treatment
5%
BAFF-R
5%
Repertoire Profiling
5%
T Helper Cells
5%
Memory B Cells
5%
Randomized Double-blind
5%
Placebo-controlled
5%
Immunology
5%
Immuno
5%
Abatacept
5%
Single Center
5%
Repertoire Analysis
5%
Extranodal Marginal Zone Lymphoma of mucosa-associated Lymphoid Tissue
5%
Giant Cell Arteritis
5%
Rheumatoid Factor
5%
Autoreactive
5%
Ankylosing Spondylitis
5%
Receptor Expression
5%
Patient Acceptable Symptom State
5%
Rituximab Therapy
5%
